PL336273A1 - Pharmaceutic composition active in stomach portion of gastrointestinal system - Google Patents

Pharmaceutic composition active in stomach portion of gastrointestinal system

Info

Publication number
PL336273A1
PL336273A1 PL98336273A PL33627398A PL336273A1 PL 336273 A1 PL336273 A1 PL 336273A1 PL 98336273 A PL98336273 A PL 98336273A PL 33627398 A PL33627398 A PL 33627398A PL 336273 A1 PL336273 A1 PL 336273A1
Authority
PL
Poland
Prior art keywords
gastrointestinal system
composition active
stomach portion
pharmaceutic composition
pharmaceutic
Prior art date
Application number
PL98336273A
Other languages
English (en)
Inventor
Jerome Besse
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of PL336273A1 publication Critical patent/PL336273A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL98336273A 1997-04-18 1998-04-15 Pharmaceutic composition active in stomach portion of gastrointestinal system PL336273A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9704803A FR2762213B1 (fr) 1997-04-18 1997-04-18 Composition pharmaceutique a retention gastrique
PCT/FR1998/000755 WO1998047506A1 (fr) 1997-04-18 1998-04-15 Composition pharmaceutique a residence gastrique

Publications (1)

Publication Number Publication Date
PL336273A1 true PL336273A1 (en) 2000-06-19

Family

ID=9506077

Family Applications (1)

Application Number Title Priority Date Filing Date
PL98336273A PL336273A1 (en) 1997-04-18 1998-04-15 Pharmaceutic composition active in stomach portion of gastrointestinal system

Country Status (19)

Country Link
EP (1) EP0983065A1 (fr)
JP (1) JP2001523241A (fr)
KR (1) KR20010006353A (fr)
CN (1) CN1252720A (fr)
AR (1) AR015586A1 (fr)
AU (1) AU737634B2 (fr)
CA (1) CA2286081A1 (fr)
FR (1) FR2762213B1 (fr)
HU (1) HUP0002455A3 (fr)
IL (1) IL131995A0 (fr)
JO (1) JO2017B1 (fr)
MA (1) MA26482A1 (fr)
NO (1) NO995039L (fr)
NZ (1) NZ500288A (fr)
PE (1) PE68199A1 (fr)
PL (1) PL336273A1 (fr)
TN (1) TNSN98049A1 (fr)
WO (1) WO1998047506A1 (fr)
ZA (1) ZA983258B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6169094B1 (en) * 1998-07-14 2001-01-02 Sanofi-Synthelabo Compositions of (S) (-)-amisulpride
FR2784583B1 (fr) 1998-10-16 2002-01-25 Synthelabo Composition pharmaceutique a residence gastrique et a liberation controlee
FR2790388B1 (fr) * 1999-03-04 2001-04-13 Synthelabo Compositions pharmaceutiques comprenant un benzamide et au moins un promoteur d'absorption
EP1245227A1 (fr) 2001-03-31 2002-10-02 Jagotec Ag Comprimé pharmaceutique flottant dans l'estomac destiné à la libération programmée du principe actif et procédé pour produire le matériel flottant compris dans le comprimé
WO2009157711A2 (fr) * 2008-06-24 2009-12-30 Park Eun-Seok Comprimé poreux gastro-rétentif et son procédé de préparation
FR2949061B1 (fr) * 2009-08-12 2013-04-19 Debregeas Et Associes Pharma Microgranules flottants
EP2719376B1 (fr) * 2012-10-12 2015-03-04 Omya International AG Formulation de médicament à rétention gastrique et systèmes d'administration et leur procédé de préparation à l'aide de carbonate de calcium fonctionnalisé
JP2021505595A (ja) 2017-12-05 2021-02-18 サノビオン ファーマシューティカルズ インクＳｕｎｏｖｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． 結晶形およびその製造方法
CN118593482A (zh) 2017-12-05 2024-09-06 赛诺维信制药公司 非外消旋混合物及其用途
JP7044649B2 (ja) * 2018-06-28 2022-03-30 株式会社ファンケル 胃内浮遊錠剤
MX2021014774A (es) 2019-06-04 2022-02-03 Sunovion Pharmaceuticals Inc Formulaciones de liberacion modificada y usos de las mismas.
WO2023214018A1 (fr) 2022-05-06 2023-11-09 Galenix Innovations Composition à libération prolongée gonflable à rétention gastrique

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2415099A1 (fr) * 1978-01-20 1979-08-17 Ile De France Nouveaux derives de 4-amino-5-alkylsulfonyl ortho-anisamides, leurs procedes de preparation et leur application comme psychotropes
FR2554718B1 (fr) * 1983-11-14 1986-04-04 Ethypharm Sa Nouvelles formes galeniques du sulpiride utilisables par voie orale
FR2556964A1 (fr) * 1983-12-23 1985-06-28 Ile De France Nouvelles formes galeniques du sulpiride utilisables par voie orale
JPS62178518A (ja) * 1986-01-30 1987-08-05 Toho Yakuhin Kogyo Kk 新規持続性スルピリド錠剤
JPH0776172B2 (ja) * 1986-04-16 1995-08-16 藤沢薬品工業株式会社 マトリツクス錠
CA2039742A1 (fr) * 1990-04-23 1991-10-24 Andrew B. Dennis Comprimes pour ingredients pharmaceutiques sujets a problemes : composition et mode de preparation

Also Published As

Publication number Publication date
NO995039L (no) 1999-12-17
CN1252720A (zh) 2000-05-10
AU7341698A (en) 1998-11-13
IL131995A0 (en) 2001-03-19
KR20010006353A (ko) 2001-01-26
HUP0002455A3 (en) 2001-01-29
FR2762213B1 (fr) 1999-05-14
AR015586A1 (es) 2001-05-16
WO1998047506A1 (fr) 1998-10-29
MA26482A1 (fr) 2004-12-20
ZA983258B (en) 1998-10-19
CA2286081A1 (fr) 1998-10-29
AU737634B2 (en) 2001-08-23
EP0983065A1 (fr) 2000-03-08
NO995039D0 (no) 1999-10-15
NZ500288A (en) 2001-03-30
FR2762213A1 (fr) 1998-10-23
TNSN98049A1 (fr) 2005-03-15
PE68199A1 (es) 1999-07-15
JP2001523241A (ja) 2001-11-20
JO2017B1 (en) 1999-05-15
HUP0002455A2 (hu) 2000-12-28

Similar Documents

Publication Publication Date Title
GB2332147B (en) Therapeutically active compositions
HUP0003761A3 (en) Substituted alkanohydroxamic acids and pharmaceutical compositions containing them
HUP0100178A3 (en) Tetrahydro-naphtiridinyl-imidazolydinyl-carboxylic acid derivatives and pharmaceutical compositions thereof
GB9713149D0 (en) Pharmaceutical formulations
GB9706089D0 (en) Pharmaceutical composition
IL135177A0 (en) Amidocarboxylic acid derivatives and pharmaceutical compositions containing the same
ZA982872B (en) Pharmaceutical formulation
HUP0002510A3 (en) Tetrazole derivatives and pharmaceutical compositions containing them
PL336273A1 (en) Pharmaceutic composition active in stomach portion of gastrointestinal system
PL344834A1 (en) Pharmaceutical levothyroxine preparation
PL336982A1 (en) Pharmaceutic compositions of peptides sparingly dissolvable in physiological media
IL136612A (en) Phenylaminoalkyl-carboxylic acid derivatives and pharmaceutical compositions containing the same
IL133928A0 (en) Pharmaceutical composition containing peptichemio
GB9717444D0 (en) Pharmaceutical composition
ZA982073B (en) Pharmaceutical preparation
GB9717428D0 (en) Pharmaceutical composition
PL336805A1 (en) Pharmaceutic agents containing thysoxanide and intazoxanide
IL187593A0 (en) Gastrointestinal drug composition
PL338856A1 (en) Dried biologically or therapeutically active preparations
GB9709739D0 (en) Pharmaceutical formulation
ZA982952B (en) Pseudo-peptide compounds their preparation and use in pharmaceutical formulations
GB9717770D0 (en) Pharmaceutical composition
HUP0004132A3 (en) Rapidly soluble drug composition
GB2321190B (en) Pharmaceutical composition
GB9726781D0 (en) Pharmaceutical composition